Page last updated: 2024-08-23

substance p and Rheumatic Diseases

substance p has been researched along with Rheumatic Diseases in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's2 (50.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bertinotti, L; Casale, R; Colangelo, N; Del Rosso, A; Matucci-Cerinic, M; Pietrini, U; Zoppi, M1
Bennett, RM1
Menkès, CJ; Renoux, M1
Ciccarelli, A; de Crescenzo, G; de Paulis, A; Marinò, D; Marinò, I; Marone, G1

Reviews

1 review(s) available for substance p and Rheumatic Diseases

ArticleYear
The use of pupillometry in joint and connective tissue diseases.
    Annals of the New York Academy of Sciences, 2002, Volume: 966

    Topics: Autoimmune Diseases; Connective Tissue Diseases; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Humans; Joint Diseases; Neurotransmitter Agents; Parasympathetic Nervous System; Pupil Disorders; Reflex, Pupillary; Rheumatic Diseases; Scleroderma, Systemic; Sjogren's Syndrome; Substance P; Sympathetic Nervous System

2002

Other Studies

3 other study(ies) available for substance p and Rheumatic Diseases

ArticleYear
Fibrositis: misnomer for a common rheumatic disorder.
    The Western journal of medicine, 1981, Volume: 134, Issue:5

    Topics: Diagnosis, Differential; Enkephalins; Fatigue; Fibromyalgia; Humans; Rheumatic Diseases; Substance P; Terminology as Topic

1981
[Substance P and rheumatic diseases].
    La Revue du praticien, 1994, Jun-15, Volume: 44, Issue:12

    Topics: Animals; Arthritis, Rheumatoid; Chondrocalcinosis; Humans; Rheumatic Diseases; Substance P

1994
Human synovial mast cells. II. Heterogeneity of the pharmacologic effects of antiinflammatory and immunosuppressive drugs.
    Arthritis and rheumatism, 1997, Volume: 40, Issue:3

    Topics: Adenosine; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chymases; Cyclosporine; Diclofenac; Histamine Release; Humans; Immunoglobulin E; Immunosuppressive Agents; Leukotriene C4; Mast Cells; Methotrexate; Middle Aged; Polyenes; Prostaglandins D; Rheumatic Diseases; Serine Endopeptidases; Sirolimus; Substance P; Sulfonamides; Synovial Membrane; Tacrolimus; Tryptases

1997